Chondroitin sulfate proteoglycans in tumor progression. 2006

Yanusz Wegrowski, and François-Xavier Maquart
CNRS UMR 6198, Faculty of Medicine, IFR-53, 51095 Reims Cedex, France.

UI MeSH Term Description Entries
D009369 Neoplasms New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms. Benign Neoplasm,Cancer,Malignant Neoplasm,Tumor,Tumors,Benign Neoplasms,Malignancy,Malignant Neoplasms,Neoplasia,Neoplasm,Neoplasms, Benign,Cancers,Malignancies,Neoplasias,Neoplasm, Benign,Neoplasm, Malignant,Neoplasms, Malignant
D009389 Neovascularization, Pathologic A pathologic process consisting of the proliferation of blood vessels in abnormal tissues or in abnormal positions. Angiogenesis, Pathologic,Angiogenesis, Pathological,Neovascularization, Pathological,Pathologic Angiogenesis,Pathologic Neovascularization,Pathological Angiogenesis,Pathological Neovascularization
D011508 Chondroitin Sulfate Proteoglycans Proteoglycans consisting of proteins linked to one or more CHONDROITIN SULFATE-containing oligosaccharide chains. Proteochondroitin Sulfates,Chondroitin Sulfate Proteoglycan,Proteochondroitin Sulfate,Proteoglycan, Chondroitin Sulfate,Proteoglycans, Chondroitin Sulfate,Sulfate Proteoglycan, Chondroitin,Sulfate Proteoglycans, Chondroitin
D002462 Cell Membrane The lipid- and protein-containing, selectively permeable membrane that surrounds the cytoplasm in prokaryotic and eukaryotic cells. Plasma Membrane,Cytoplasmic Membrane,Cell Membranes,Cytoplasmic Membranes,Membrane, Cell,Membrane, Cytoplasmic,Membrane, Plasma,Membranes, Cell,Membranes, Cytoplasmic,Membranes, Plasma,Plasma Membranes
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D018450 Disease Progression The worsening and general progression of a disease over time. This concept is most often used for chronic and incurable diseases where the stage of the disease is an important determinant of therapy and prognosis. Clinical Course,Clinical Progression,Disease Exacerbation,Exacerbation, Disease,Progression, Clinical,Progression, Disease

Related Publications

Yanusz Wegrowski, and François-Xavier Maquart
January 2006, Advances in pharmacology (San Diego, Calif.),
Yanusz Wegrowski, and François-Xavier Maquart
August 1978, Biochemical and biophysical research communications,
Yanusz Wegrowski, and François-Xavier Maquart
June 1996, Seminars in cancer biology,
Yanusz Wegrowski, and François-Xavier Maquart
January 2004, Postepy biochemii,
Yanusz Wegrowski, and François-Xavier Maquart
January 2021, Methods in molecular biology (Clifton, N.J.),
Yanusz Wegrowski, and François-Xavier Maquart
February 2005, Current opinion in neurobiology,
Yanusz Wegrowski, and François-Xavier Maquart
September 2012, Annals of neurology,
Yanusz Wegrowski, and François-Xavier Maquart
April 2007, Sheng li ke xue jin zhan [Progress in physiology],
Yanusz Wegrowski, and François-Xavier Maquart
January 2010, Frontiers in bioscience (Landmark edition),
Yanusz Wegrowski, and François-Xavier Maquart
July 1989, The Journal of biological chemistry,
Copied contents to your clipboard!